Douglas D. Watts

Array ( [id] => 4101586 [patent_doc_number] => 06051417 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-18 [patent_title] => 'Prostate cancer drug screening using hKLK2 enhancer' [patent_app_type] => 1 [patent_app_number] => 8/906192 [patent_app_country] => US [patent_app_date] => 1997-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 9694 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/051/06051417.pdf [firstpage_image] =>[orig_patent_app_number] => 906192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4136012 [patent_doc_number] => 06121415 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'ErbB4 receptor-specific neuregolin related ligands and uses therefor' [patent_app_type] => 1 [patent_app_number] => 8/899437 [patent_app_country] => US [patent_app_date] => 1997-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 39917 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/121/06121415.pdf [firstpage_image] =>[orig_patent_app_number] => 899437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4189753 [patent_doc_number] => 06043044 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-28 [patent_title] => 'Macrophage migration inhibitory factor as diagnostic and prognostic marker for metastatic adenocarcinoma' [patent_app_type] => 1 [patent_app_number] => 8/893204 [patent_app_country] => US [patent_app_date] => 1997-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3449 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/043/06043044.pdf [firstpage_image] =>[orig_patent_app_number] => 893204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4192771 [patent_doc_number] => 06013252 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Method promoting conception by administering IL-8 or MCAF' [patent_app_type] => 1 [patent_app_number] => 8/817941 [patent_app_country] => US [patent_app_date] => 1997-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 7050 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013252.pdf [firstpage_image] =>[orig_patent_app_number] => 817941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3998490 [patent_doc_number] => 05858694 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Method for identifying compounds for inhibition of cancerous lesions' [patent_app_type] => 1 [patent_app_number] => 8/866027 [patent_app_country] => US [patent_app_date] => 1997-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 8414 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858694.pdf [firstpage_image] =>[orig_patent_app_number] => 866027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4181378 [patent_doc_number] => 06037461 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same' [patent_app_type] => 1 [patent_app_number] => 8/859167 [patent_app_country] => US [patent_app_date] => 1997-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 19 [patent_no_of_words] => 16723 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/037/06037461.pdf [firstpage_image] =>[orig_patent_app_number] => 859167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4188760 [patent_doc_number] => 06093809 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-25 [patent_title] => 'Telomerase' [patent_app_type] => 1 [patent_app_number] => 8/851843 [patent_app_country] => US [patent_app_date] => 1997-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 71 [patent_figures_cnt] => 80 [patent_no_of_words] => 73789 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/093/06093809.pdf [firstpage_image] =>[orig_patent_app_number] => 851843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4152290 [patent_doc_number] => 06107090 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains' [patent_app_type] => 1 [patent_app_number] => 8/838682 [patent_app_country] => US [patent_app_date] => 1997-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13933 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/107/06107090.pdf [firstpage_image] =>[orig_patent_app_number] => 838682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4213133 [patent_doc_number] => 06110702 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'PSA positive regulating (PSAR) sequences and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/828972 [patent_app_country] => US [patent_app_date] => 1997-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 16 [patent_no_of_words] => 12158 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110702.pdf [firstpage_image] =>[orig_patent_app_number] => 828972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4045440 [patent_doc_number] => 05874543 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'Antibodies to PF4A receptor' [patent_app_type] => 1 [patent_app_number] => 8/805478 [patent_app_country] => US [patent_app_date] => 1997-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 23 [patent_no_of_words] => 24191 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874543.pdf [firstpage_image] =>[orig_patent_app_number] => 805478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3994863 [patent_doc_number] => 05922541 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Method for detection of PF4A receptor nucleic acid' [patent_app_type] => 1 [patent_app_number] => 8/801228 [patent_app_country] => US [patent_app_date] => 1997-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 23 [patent_no_of_words] => 25575 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922541.pdf [firstpage_image] =>[orig_patent_app_number] => 801228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3995980 [patent_doc_number] => 05919896 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'PF4A receptor' [patent_app_type] => 1 [patent_app_number] => 8/801238 [patent_app_country] => US [patent_app_date] => 1997-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 23 [patent_no_of_words] => 25184 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919896.pdf [firstpage_image] =>[orig_patent_app_number] => 801238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3994663 [patent_doc_number] => 05892017 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Nucleic acid encoding PF4A receptor' [patent_app_type] => 1 [patent_app_number] => 8/802627 [patent_app_country] => US [patent_app_date] => 1997-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 23 [patent_no_of_words] => 24190 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/892/05892017.pdf [firstpage_image] =>[orig_patent_app_number] => 802627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3790036 [patent_doc_number] => 05840871 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Prostate-associated kallikrein' [patent_app_type] => 1 [patent_app_number] => 8/790137 [patent_app_country] => US [patent_app_date] => 1997-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17167 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840871.pdf [firstpage_image] =>[orig_patent_app_number] => 790137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4137652 [patent_doc_number] => 06060253 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Agents that bind to and inhibit human cytochrome P450 2D6' [patent_app_type] => 1 [patent_app_number] => 8/788599 [patent_app_country] => US [patent_app_date] => 1997-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9045 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060253.pdf [firstpage_image] =>[orig_patent_app_number] => 788599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3994650 [patent_doc_number] => 05892016 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Human tumor suppressor' [patent_app_type] => 1 [patent_app_number] => 8/786999 [patent_app_country] => US [patent_app_date] => 1997-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17471 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/892/05892016.pdf [firstpage_image] =>[orig_patent_app_number] => 786999 [rel_patent_id] =>[rel_patent_doc_number] =>)